These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 3077281)

  • 1. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM; Wood MJ
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target.
    James PA; Reeves DS
    J Chemother; 1996 Feb; 8 Suppl 2():37-47. PubMed ID: 8738845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cephalosporins: bacterial resistance measured by penicillin-binding proteins].
    Garrido J; López F
    Rev Med Chil; 1989 Sep; 117(9):1037-43. PubMed ID: 2519470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting of the penicillin binding proteins that are the target for inhibition by beta-lactams as a likely mechanism of resistance to antibiotics during therapy.
    Satta G; Canepari P; Maurici R; Pompei R; Marcialis MA
    Chemioterapia; 1985 Feb; 4(1):113-5. PubMed ID: 3986940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
    Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S
    J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin-binding proteins and peptidoglycan peptide-interacting proteins.
    Rodríguez-Tébar A; Vázquez D
    Microbiol Sci; 1984 Dec; 1(9):211-4. PubMed ID: 6444131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
    Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
    Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
    Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacylation kinetics analysis of Streptococcus pneumoniae penicillin-binding protein 2x mutants resistant to beta-lactam antibiotics using electrospray ionization- mass spectrometry.
    Di Guilmi AM; Mouz N; Pétillot Y; Forest E; Dideberg O; Vernet T
    Anal Biochem; 2000 Sep; 284(2):240-6. PubMed ID: 10964406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.